SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52 | -59.7% | 87,000 | -12.4% | 0.00% | -66.7% |
| Q2 2023 | $129 | +95.5% | 99,352 | +163.5% | 0.00% | +200.0% |
| Q1 2023 | $66 | -40.5% | 37,710 | +5.9% | 0.00% | -50.0% |
| Q4 2022 | $111 | -99.9% | 35,620 | -18.8% | 0.00% | -66.7% |
| Q3 2022 | $214,000 | +336.7% | 43,877 | +264.2% | 0.01% | +500.0% |
| Q2 2022 | $49,000 | -25.8% | 12,048 | +5.9% | 0.00% | -50.0% |
| Q1 2022 | $66,000 | +127.6% | 11,376 | +242.1% | 0.00% | +100.0% |
| Q3 2021 | $29,000 | -25.6% | 3,325 | +1.5% | 0.00% | 0.0% |
| Q2 2021 | $39,000 | -2.5% | 3,275 | +0.6% | 0.00% | 0.0% |
| Q1 2021 | $40,000 | -21.6% | 3,255 | -0.5% | 0.00% | 0.0% |
| Q4 2020 | $51,000 | +363.6% | 3,270 | +171.6% | 0.00% | – |
| Q3 2020 | $11,000 | – | 1,204 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |